Eden Research CEO on German approval for Mevalone, new head of regulatory affairs

Proactive - Interviews for investors

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive's Stephen Gunnion about the regulatory approval of the company's biofungicide, Mevalone, in Germany. This marks the fourth approval for the product within the past year, a significant milestone given Germany's key position in the European Union's central zone. The biofungicide has been authorised for use on grapes and apples, two of Germany's major crops, combating the disease Botrytis which thrives due to the country's weather conditions. Smith highlighted the importance of this approval, noting the strong existing partnership with Sumi Agro Germany, part of Sumitomo Corporation, which positions Eden Research well for rapid market entry. Although the approval came late in the season, efforts are underway to ensure Mevalone reaches growers this year, with a more substantial impact expected on the company’s revenue in the following year. Smith also mentioned the strategic appointment of a new head of regulatory affairs, Ilshad Moulan, who is expected to streamline the process as Eden Research continues to expand into new jurisdictions. This development follows the successful tenure of Dr Mike Carroll, who significantly strengthened the company's regulatory capabilities. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #EdenResearch #Biofungicide #Agritech #SustainableFarming #CropProtection #GermanAgriculture #Botrytis #Fungicide #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews